{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:12:48Z","timestamp":1793707968842,"version":"4.6.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gambro"},{"name":"National Institutes of Health, Health Resources and Services Administration, European Commission, Amgen, Medtronic, Novartis, and Otsuka","id":[{"id":"https:\/\/ror.org\/0121dpf30","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Boston Scientific, Medtronic, Vifor Pharma, and the National Medical Research Council of Singapore","id":[{"id":"https:\/\/ror.org\/04x3cxs03","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Roche Diagnostics Japan and Otsuka"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jacc.2013.11.053","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T16:00:40Z","timestamp":1391616040000},"page":"1123-1133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1885,"title":["The Global Health and Economic Burden of\u00a0Hospitalizations for Heart Failure"],"prefix":"10.1016","volume":"63","author":[{"given":"Andrew P.","family":"Ambrosy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savina","family":"Nodari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2013.11.053_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.11.053_bib2","first-page":"e2","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.11.053_bib3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib5","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib6","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacc.2012.12.038","article-title":"Heart failure associated hospitalizations in the United States","volume":"61","author":"Blecker","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10741-007-9009-2","article-title":"Epidemiology of acute heart failure syndromes","volume":"12","author":"Alla","year":"2007","journal-title":"Heart Fail Rev"},{"issue":"Suppl 5","key":"10.1016\/j.jacc.2013.11.053_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/europace\/eup304","article-title":"Heart failure burden and therapy","volume":"11","author":"Zannad","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2013.11.053_bib9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998\u20132008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib10","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/jama.2011.1510","article-title":"Hospitalizations for heart failure in the United States\u2014a sign of hope","volume":"306","author":"Gheorghiade","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ehj.2003.12.012","article-title":"Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000","volume":"25","author":"Schaufelberger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/euhj.2000.2291","article-title":"Trends in hospitalization for heart failure in Scotland, 1990\u20131996. An epidemic that has reached its peak?","volume":"22","author":"Stewart","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/heart.87.1.75","article-title":"Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic?","volume":"87","author":"Mosterd","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2013.11.053_bib14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jacc.2008.07.056","article-title":"Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program","volume":"52","author":"Blair","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib16","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.11.053_bib18","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib19","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/eurjhf\/hfq154","article-title":"EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"12","author":"Maggioni","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurjhf\/hfs117","article-title":"Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome","volume":"14","author":"Oliva","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ejheart.2006.01.001","article-title":"Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study","volume":"8","author":"Zannad","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ahj.2011.03.033","article-title":"The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry","volume":"162","author":"Chioncel","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib23","doi-asserted-by":"crossref","first-page":"R291","DOI":"10.1186\/cc10584","article-title":"Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry","volume":"15","author":"Spinar","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2013.11.053_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1253\/circj.CJ-13-0187","article-title":"Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry)","volume":"77","author":"Sato","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2013.11.053_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cardfail.2011.09.003","article-title":"Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific)","volume":"18","author":"Atherton","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00134-010-2113-0","article-title":"Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)","volume":"37","author":"Follath","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacc.2013.11.053_bib27","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.2013.1063","article-title":"Strategies and opportunities for drug development in heart failure","volume":"309","author":"Butler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jama.2012.205110","article-title":"Thirty-day readmissions: the clock is ticking","volume":"309","author":"Vaduganathan","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jacc.2009.02.066","article-title":"Heart failure in women: a need for prospective data","volume":"54","author":"Hsich","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2013.11.053_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cardfail.2005.09.005","article-title":"Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"12","author":"Galvao","year":"2006","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ahj.2011.12.013","article-title":"Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction","volume":"163","author":"Hsich","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib33","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ahj.2011.01.012","article-title":"Association of race\/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure","volume":"161","author":"Thomas","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archinte.168.11.1152","article-title":"Characteristics and outcomes in African American patients with decompensated heart failure","volume":"168","author":"Kamath","year":"2008","journal-title":"Archives of internal medicine"},{"key":"10.1016\/j.jacc.2013.11.053_bib35","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jacc.2008.01.028","article-title":"Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry","volume":"51","author":"Yancy","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jama.300.4.431","article-title":"Heart failure with preserved ejection fraction: treat now by treating comorbidities","volume":"300","author":"Shah","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib38","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-005-6127-6","article-title":"Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry","volume":"9","author":"Fonarow","year":"2004","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2013.11.053_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjcard.2007.07.067","article-title":"Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)","volume":"101","author":"Young","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib41","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in\u00a0patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry","volume":"28","author":"Gheorghiade","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib42","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib43","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1001\/jama.299.22.2656","article-title":"Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction","volume":"299","author":"Wang","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib44","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2013.11.053_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrcardio.2010.205","article-title":"Heart failure in 2010: one step forward, two steps back","volume":"8","author":"Gheorghiade","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrcardio.2012.181","article-title":"The disconnect between phase II and phase III trials of drugs for heart failure","volume":"10","author":"Vaduganathan","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib48","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.amjcard.2004.02.051","article-title":"Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)","volume":"93","author":"Gattis","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib49","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehs191","article-title":"Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section","volume":"33","author":"Januzzi","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib50","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2010.06.016","article-title":"Troponin elevation in heart failure prevalence, mechanisms, and clinical implications","volume":"56","author":"Kociol","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib51","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib52","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jacc.2003.12.040","article-title":"Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial","volume":"43","author":"Gattis","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib53","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1067\/mhj.2003.157","article-title":"Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study","volume":"145","author":"Gheorghiade","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib54","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.jacc.2004.01.041","article-title":"Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge","volume":"43","author":"Butler","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ebm1307","article-title":"Eplerenone reduces risk of cardiovascular death or hospitalisation in heart failure patients with reduced ejection fraction","volume":"16","author":"Ambrosy","year":"2011","journal-title":"Evidence-based medicine"},{"key":"10.1016\/j.jacc.2013.11.053_bib56","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.11.053_bib57","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10741-011-9247-1","article-title":"The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes","volume":"16","author":"Wang","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2013.11.053_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10741-011-9237-3","article-title":"The potential role of cardiac resynchronization therapy in acute heart failure syndromes","volume":"16","author":"Wang","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2013.11.053_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10741-011-9243-5","article-title":"Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions","volume":"16","author":"Wang","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2013.11.053_bib61","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","article-title":"EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib62","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ahj.2010.02.023","article-title":"Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program","volume":"159","author":"O'Connor","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjcard.2009.02.057","article-title":"Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF)","volume":"104","author":"Fonarow","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib64","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ejheart.2008.09.009","volume":"10","author":"Rossi","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCHEARTFAILURE.111.965681","article-title":"Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure","volume":"5","author":"Mountantonakis","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib66","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.amjcard.2008.07.045","article-title":"Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)","volume":"102","author":"Fonarow","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib67","doi-asserted-by":"crossref","first-page":"277.e1","DOI":"10.1016\/j.ahj.2007.05.001","article-title":"Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"154","author":"Greenberg","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib68","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/eurjhf\/hfs009","article-title":"Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF","volume":"14","author":"Mentz","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"52","author":"Abraham","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib70","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","article-title":"Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure","volume":"49","author":"Fonarow","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib71","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.amjcard.2007.07.066","article-title":"Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE","volume":"101","author":"Fonarow","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib72","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","article-title":"Cardiac troponin and outcome in acute heart failure","volume":"358","author":"Peacock","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.11.053_bib73","doi-asserted-by":"crossref","first-page":"82.e1","DOI":"10.1016\/j.ahj.2006.10.008","article-title":"Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"153","author":"Fonarow","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib74","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jacc.2008.03.048","article-title":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program","volume":"52","author":"Fonarow","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib75","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib76","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ahj.2008.04.030","article-title":"Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"156","author":"O'Connor","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib77","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cardfail.2010.08.010","article-title":"Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions","volume":"17","author":"Giamouzis","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2013.11.053_bib78","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ahj.2007.03.012","article-title":"Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"153","author":"Fonarow","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2004.03.004","article-title":"Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design","volume":"148","author":"Fonarow","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib80","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archinte.167.14.1493","article-title":"Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)","volume":"167","author":"Fonarow","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2013.11.053_bib81","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ahj.2009.07.031","article-title":"Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure","volume":"158","author":"Heidenreich","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.11.053_bib82","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrcardio.2010.102","article-title":"Heart failure: Early follow-up after hospitalization for heart failure","volume":"7","author":"Gheorghiade","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib83","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/CIRCULATIONAHA.110.982207","article-title":"Postdischarge assessment after a heart failure hospitalization: the next step forward","volume":"122","author":"Metra","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.11.053_bib84","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.2010.1147","article-title":"Early physician follow-up and 30-day readmission among older patients with heart failure","volume":"304","author":"Wexler","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib85","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/jama.2010.533","article-title":"Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure","volume":"303","author":"Hernandez","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.11.053_bib86","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jacc.2012.10.025","article-title":"Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial","volume":"61","author":"Butler","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.11.053_bib87","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10741-012-9361-8","article-title":"Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions","volume":"19","author":"Gheorghiade","year":"2014","journal-title":"Heart Fail Rev"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714002915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714002915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:04:48Z","timestamp":1760015088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714002915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0735109714002915"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2013.11.053","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Global Health and Economic Burden of\u00a0Hospitalizations for Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2013.11.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}